Product
Adebrelimab,Fruquintinib
2 clinical trials
1 indication
Indication
Stomach CancerClinical trial
Phase II Clinical Study of Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Second-line Treatment of Advanced Gastric CancerStatus: Recruiting, Estimated PCD: 2026-10-10
Clinical trial
Phase II Clinical Study of Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer After First-line Treatment With PD-1 Antibody FailedStatus: Recruiting, Estimated PCD: 2026-10-10